>
Industry
Biotechnology
Topic
Mergers and Acquisitions
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Mergers and Acquisitions in Biotechnology

... in the three countries from a small Toronto company then named Scythian Biosciences Corp. Aphria and some of its executives, including chief executive Vic Neufeld, ...
... binding letter of intent dated October 22, 2018 (the "LOI") with FSD Pharma Inc. ("FSD") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) for the acquisition of ...
... Riverside Partners has sold BioAgilytix to Cobepa. No financial terms were disclosed. Based in North Carolina’s Research ...
... authorization by $9 billion, on top of a previously authorized $15 billion. Gilead Sciences – Gilead named Roche executive Daniel O'Day as its new chief ...
... PR Newswire Amgen (NASDAQ:AMGN) and the Lazarex Cancer Foundation, a non-profit organization focused on improving ...
... PR Newswire - genOway to acquire exclusive rights to MilliporeSigma's foundational genome-editing patents to produce, sell ...
... PR Newswire (PBT.U: CSE, PTGEF: OTC Markets) -Portage Biotech Inc. ("Portage" or the "Company") is pleased to announce that it has ...
... Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ...
... Moderna market value shrinks to $6.1 billion Moderna shares sank on their first ...
... Friday, readers! Amid a rocky market that’s whipsawed on a near-daily basis, Moderna Therapeutics pulled off the improbable late Thursday: An historic IPO in which ...
Subscribe now for full coverage on Mergers and Acquisitions in Biotechnology
Start My Free Trial